Doping control for the team physician: A review of drug testing procedures in sport

American Journal of Sports Medicine

Volumn 34, Issue 10, 2006, Pages 1690-1698

  Green, Gary A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anabolic androgenic steroids; Drug education; Drug testing; Erythropoietin; Human growth hormone

Indexed keywords

ALCOHOL; ANABOLIC AGENT; ANDROGEN; ANTIESTROGEN; AROMATASE INHIBITOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOLDENONE; CANNABIS; CENTRAL STIMULANT AGENT; CORTICOTROPIN; DIURETIC AGENT; EPHEDRINE; EPITESTOSTERONE; ERYTHROPOIETIN; GLUCOCORTICOID; GONADOTROPIN; GROWTH HORMONE; INSULIN; METANDIENONE; NANDROLONE; NARCOTIC AGENT; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OXANDROLONE; OXYMETHOLONE; SALBUTAMOL; STANOZOLOL; TESTOSTERONE; TRENBOLONE; UNINDEXED DRUG;

COUNSELING; DOPING; DRUG SCREENING; EDUCATION; HEALTH PROGRAM; HUMAN; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SPORTS MEDICINE;

DOPING IN SPORTS; ERYTHROPOIETIN; GUIDELINE ADHERENCE; GUIDELINES; GUIDELINES AS TOPIC; HEMATINICS; HUMAN GROWTH HORMONE; HUMANS; SPORTS MEDICINE; STEROIDS; SUBSTANCE ABUSE DETECTION;

EID: 33748649081     PISSN: 03635465     EISSN: 15523365     Source Type: Journal    
DOI: 10.1177/0363546506293022     Document Type: Review

References (32)

1. Ayotte C. Significance of 19-norandrosterone in athlete's urine samples. Br J Sports Med. 2006;40:25-29.
2. Baume N, Avois L, Schweizer C, et al. [13C]Nandrolone excretion in trained athletes: interindividual variability in metabolism. Clin Chem. 2004;50:355-364.
3. Breidbach A. Erythropoietin (EPO)/darbepoetin. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:431-433.
4. Catlin DH, Ahrens B, Kucherova Y. Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine. Rapid Commun Mass Spectrom. 2002;16:1273-1275.
5. Catlin DH, Breidbach A, Elliott S, Glaspy J. Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human EPO, and endogenous EPO from human urine. Clin Chem. 2002;48:2057-2059.
6. Catlin DH, Hatton CK, Starcevic SH. Issues in detecting abuse of xenobiotic anabolic steroids and testosterone by analysis of athlete's urine. Clin Chem. 1997;43:1280-1288.
7. Catlin DH, Leder BZ, Ahrens B, et al. Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite. JAMA. 2000;284:2618-2621.
8. Catlin DH, Sekera MH, Ahrens BD, Starcevic B, Chang YC, Hatton CK. Tetrahydrogestrinone: discovery, synthesis, and detection in urine. Rapid Commun Mass Spectrom. 2004;18:1245-1249.
9. Donike M, Barwald KR, Klosterman K, et al. The detection of exogenous testosterone. In: Heck H, Hollmann W, Liesen H, Rost R, eds. Sport: Leistung und Gesundheit. Cologne, Germany: Deutscher Arzte Verlag; 1983:293-300.
10. Elliot DL, Goldberg L, Moe EL, Defrancesco CA, Durham MB, Hix-Small H. Preventing substance use and disordered eating: initial outcomes of the ATHENA (Athletes Targeting Healthy Exercise and Nutrition Alternatives) program. Arch Pediatr Adolesc Med. 2004;158:1043-1049.
11. Goldberg L, Elliot DL, Clarke GN, et al. Effects of a multidimensional anabolic steroid prevention intervention: the Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. JAMA. 1996;276:1555-1562.
12. Green GA. Anabolic agents. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:59-61.
13. Green GA. Cannabinoids. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:208-209.
14. Green GA. HGH/somatomedins. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:624-625.
15. Green GA, Catlin DH, Starcevic B. Analysis of over-the-counter dietary supplements. Clin J Sport Med. 2001;11:254-259.
16. Hatton CK. Carbon isotope ratio testing. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:216-218.
17. Hatton CK. Nandrolone. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:900-901.
18. Hoberman J. Sports physicians and the doping crisis in elite sport. Clin J Sport Med. 2002;12:203-208.
19. Lasne F, De Ceaurriz J. Recombinant erythropoietin in urine. Nature. 2000;405:635.
20. Le Bizec B, Gaudin I, Monteau F, et al. Consequences of boar edible tissue consumption on urinary profiles of nandrolone metabolites. Rapid Commun Mass Spectrom. 2000;14:1058-1065.
21. National Collegiate Athletic Association. National Collegiate Athletic Association 2005 Study of Substance Use Habits of College Student-Athletes. Indianapolis, Ind: National Collegiate Athletic Association; 2006.
22. Parisotto R, Wu M, Ashenden MJ, et al. Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica. 2001;86:128-137.
23. Schmitt N, Flament M, Goubault C, Legros P, Grenier-Loustalot MF, Denjean A. Nandrolone excretion is not increased by exhaustive exercise in trained athletes. Med Sci Sports Exerc. 2002;34:1436-1439.
24. Sekera MH, Ahrens B, Chang YC, Starcevic B, Georgakopoulos C, Catlin DH. Another designer steroid: discovery, synthesis, and detection of "madol" in urine. Rapid Commun Mass Spectrom. 2005;19:781-784.
25. Tokish JM, Kocher MS, Hawkins RJ. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med. 2004;32:1543-1553.
26. UK Sport. Nandrolone progress report to the UK Sports Council from the Expert Committee on Nandrolone. Available at: www.uksport.gov .uk/images/uploaded/Nandrolone_Progress_Report_Feb03.pdf. Accessed September 3, 2003.
27. Uryasz F. Chain of custody issues. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:255-256.
28. Uryasz F. Collection issues. In: Bartlett R, Gratton C, Rolf CR, eds. Encyclopedia of International Sports Studies. New York, NY: Routledge; 2006:278-280.
29. World Anti-doping Agency. International standard for therapeutic use exemptions. Available at: http://www.wada-ama.org/rtecontent/document/ international_standard.pdf. Accessed December 22, 2005.
30. World Anti-doping Agency. The 2006 prohibited list international standard. Available at: http://www.wada-ama.org/rtecontent/document/ 2006_LIST.pdf. Accessed December 22, 2005.
31. World Anti-doping Agency. World anti-doping code. Available at: http://www.wada-ama.org/rtecontent/document/code_v3.pdf. Accessed January 9, 2006.
32. Zida W, Bildingmaier M, Dall R, Strasburger CJ. Detection of doping with human growth hormone. Lancet. 1999;353:895.